HomeNASDAQ:VRTX

NASDAQ:VRTX

Vertex Pharmaceuticals Nears Breakthrough, Stock Dubbed a Wise Investment

Vertex Pharmaceuticals Nears Breakthrough, Stock Dubbed a Wise Investment

May 13, 2024

Vertex Exceeds Q1 Profit Estimates on Cystic Fibrosis Demand

Vertex Exceeds Q1 Profit Estimates on Cystic Fibrosis Demand

May 6, 2024

Vertex’s Non-Opioid Pain Medication Achieves Primary Objective in Late-Stage Trials

Vertex’s Non-Opioid Pain Medication Achieves Primary Objective in Late-Stage Trials

January 31, 2024